SOCIETE BEYNOISE DE PHARMACIE
0459.092.882 · rovalta.com · 28/09/2026
SOCIETE BEYNOISE DE PHARMACIE
Company — Normal situation.
Financial year 2023 · Closed on 31/12/2023
Overview
Identity
Source · BCE/KBOSOCIETE BEYNOISE DE PHARMACIE is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0459.092.882
- Legal form
- Private limited company
- Contributed capital
- 18 750,00 €
- Latest accounts
- 31/12/2023
Joint committees (1)
- 313
Financials
Source · NBB, 27 filingsTrend over 18 financial years
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 80,4 k € | -3.6% | 83,3 k € | – | – | – | |||
| EBITDA | 77,4 k € | -10.4% | 86,3 k € | -36.2% | 135,4 k € | -57.0% | 314,8 k € | -10.7% | 352,4 k € |
| Operating result | 59 k € | -12.3% | 67,2 k € | -44.9% | 122 k € | -58.7% | 295,6 k € | -9.7% | 327,3 k € |
| Net result | 73,1 k € | +11.8% | 65,4 k € | -14.4% | 76,4 k € | -65.6% | 221,9 k € | -3.4% | 229,7 k € |
| Balance sheet | |||||||||
| Equity | 2,4 M € | +3.2% | 2,3 M € | +2.9% | 2,2 M € | +3.6% | 2,1 M € | +11.6% | 1,9 M € |
| Total assets | 2,4 M € | +3.5% | 2,3 M € | +0.7% | 2,3 M € | -7.2% | 2,5 M € | +10.4% | 2,2 M € |
| Cash | 538,4 € | +46.6% | 367,2 € | -70.3% | 1,2 k € | -99.9% | 1,6 M € | +2.4% | 1,5 M € |
| Debts | 20,8 k € | +49.9% | 13,9 k € | -77.9% | 63 k € | -75.4% | 255,6 k € | +5.8% | 241,7 k € |
| Other | |||||||||
| Workforce | – | – | 5,1 ETP | -16.4% | 6,1 ETP | +13.0% | 5,4 ETP | ||
Board of directors
Source · NBB, accounts to 31/12/20231 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 01/11/2021 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Alexis LECHANTEUR | Directoruntil 31/10/2021Manager |
Financials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 |
| Closing of the financial year | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 14/05/2024 | 25/04/2023 | 04/05/2022 | 16/06/2021 | 24/06/2020 | 18/06/2019 |
| General meeting | 29/04/2024 | 24/04/2023 | 25/04/2022 | 03/06/2021 | 25/05/2020 | 17/06/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 27 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2023 | 29/04/2024 | 14/05/2024 | French | |
| Abridged model | 31/12/2022 | 24/04/2023 | 25/04/2023 | French | |
| Abridged model | 31/12/2021 | 25/04/2022 | 04/05/2022 | French | |
| Abridged model | 31/12/2020 | 03/06/2021 | 16/06/2021 | French | |
| Abridged model | 31/12/2019 | 25/05/2020 | 24/06/2020 | French | |
| Abridged model | 31/12/2018 | 17/06/2019 | 18/06/2019 | French | |
| Abridged model | 31/12/2017 | 18/06/2018 | 05/07/2018 | French | |
| Abridged model | 31/12/2016 | 30/06/2017 | 28/07/2017 | French | |
| Abridged model | 31/12/2015 | 30/06/2016 | 05/08/2016 | French | |
| Abridged model | 31/12/2014 | 30/06/2015 | 28/07/2015 | French | |
| Abridged model | 31/12/2013 | 27/06/2014 | 28/07/2014 | French | |
| Abridged model | 31/12/2012 | 29/06/2013 | 25/07/2013 | French | |
| Abridged model | 31/12/2011 | 16/08/2012 | 28/08/2012 | French | |
| Abridged model | 31/12/2010 | 29/06/2011 | 19/07/2011 | French | |
| Abridged model | 31/12/2009 | 30/06/2010 | 29/07/2010 | French | |
| Abridged model | 31/12/2008 | 30/06/2009 | 29/07/2009 | French | |
| Abridged model | 31/12/2007 | 18/07/2008 | 25/08/2008 | French | |
| Abridged model | 31/12/2006 | 18/06/2007 | 30/07/2007 | French | |
| Abridged model | 31/12/2005 | 26/06/2006 | 18/07/2006 | French | |
| Abridged model | 31/12/2004 | 23/05/2005 | 15/06/2005 | French | |
| Abridged model | 31/12/2003 | 11/05/2004 | 11/06/2004 | French | |
| Abridged model | 31/12/2002 | 09/07/2003 | 14/07/2003 | French | |
| Abridged model | 31/12/2001 | 26/06/2002 | 14/08/2002 | French | |
| Abridged model | 31/12/2000 | 14/06/2001 | 11/07/2001 | French | |
| Abridged model | 31/12/1999 | 03/08/2000 | 03/10/2000 | French | |
| Abridged model | 31/12/1998 | 06/08/1999 | 16/09/1999 | French | |
| Abridged model | 31/12/1997 | 25/05/1998 | 19/06/1998 | French | — |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20231 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 01/11/2021 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Alexis LECHANTEUR | Directoruntil 31/10/2021Manager |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution23/07/2024DISSOLUTION
- Restructuring27/05/2024Projet commun de fusion
- Mandates31/05/2023DEMISSIONS, NOMINATIONS
- Mandates16/11/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - SIEGE SOCIAL - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
- Mandates23/04/2007DEMISSIONS, NOMINATIONS
- Mandates23/11/2006DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue de Mangombroux 161, 4800 Verviers | accounts 2021 → 2023 | Accounts 2023 · 2024-00089102 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| SOCIETE BEYNOISE DE PHARMACIE | accounts 2022 → 2023 | Accounts 2023 · 2024-00089102 |
| SOBEPHAR | accounts 2021 | Accounts 2021 · 2022-20022471 |
Events
- 2023Annual accounts 202373,1 k €↑
- 2022Annual accounts 202265,4 k €↓
- 2022Name changeSOCIETE BEYNOISE DE PHARMACIE
- 2021Annual accounts 202176,4 k €↓
- 2020Annual accounts 2020221,9 k €↓
- 2019Annual accounts 2019229,7 k €↑
- 2018Annual accounts 2018179,9 k €↑
- 2017Annual accounts 2017165,4 k €↑
- 2016Annual accounts 2016145,7 k €↓
- 2015Annual accounts 2015155,2 k €↓
- 2014Annual accounts 2014161 k €↑
- 2013Annual accounts 2013151 k €↑
- 2012Annual accounts 2012130,5 k €↑
- 2011Annual accounts 2011111,9 k €↓
- 2010Annual accounts 2010134,6 k €↑
- 2009Annual accounts 2009120,9 k €↑
- 2008Annual accounts 2008115,9 k €↑
- 2007Annual accounts 200785,9 k €↑
- 2006Annual accounts 200637,1 k €